Most shocking to CARD workers was the termination of lead researcher Kendall Van Keuren-Jensen, who was announced internally ...

A hidden phase of Alzheimer’s appears decades before symptoms, offering a chance for early detection and treatment.

A 75-year-old man with a genetic predisposition for Alzheimer’s has yet to show signs of the disease. Could this offer ...

Alzheimer’s disease — which affects an estimated 7 million Americans — is notoriously difficult to detect, especially in its ...

A man who should have developed early-onset Alzheimer's disease due to a genetic mutation is still symptom-free in his 70s.

Alzheimer’s disease is one of the toughest medical issues that disrupts a person's daily life. Thankfully, medical advances ...

A study reveals how a common gut bacterium may accelerate Alzheimer’s disease, reshaping medical perspectives on brain health ...

On Join Dementia Research's tenth anniversary we look at what taking part in a study into sleep, Down's syndrome and dementia ...

Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes for longer periods of time.

A medical research center named after former U.S. Sen. Roy Blunt of Missouri is facing drastic workforce reductions as part ...

Feb. 11, 2025 — A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way ...

Iowa native is the third member of his family to be diagnosed with Alzheimer's. Now, his community is rallying around him.